Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Invested Capital (2018 - 2025)

Exagen (XGN) has disclosed Invested Capital for 8 consecutive years, with $40.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital rose 40.91% year-over-year to $40.4 million, compared with a TTM value of $40.4 million through Dec 2025, up 40.91%, and an annual FY2025 reading of $40.4 million, up 40.91% over the prior year.
  • Invested Capital was $40.4 million for Q4 2025 at Exagen, down from $41.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $128.3 million in Q1 2021 and bottomed at $26.2 million in Q1 2025.
  • Average Invested Capital over 5 years is $66.4 million, with a median of $49.1 million recorded in 2023.
  • The sharpest move saw Invested Capital surged 67.57% in 2021, then tumbled 44.23% in 2023.
  • Year by year, Invested Capital stood at $112.4 million in 2021, then crashed by 37.05% to $70.8 million in 2022, then plummeted by 41.5% to $41.4 million in 2023, then crashed by 30.81% to $28.6 million in 2024, then surged by 40.91% to $40.4 million in 2025.
  • Business Quant data shows Invested Capital for XGN at $40.4 million in Q4 2025, $41.1 million in Q3 2025, and $44.0 million in Q2 2025.